These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8839689)

  • 1. Bioequivalence assessment: a pharmaceutical industry perspective.
    Godbillon J; Cardot JM; Lecaillon JB; Lefevre G; Sioufi A
    Eur J Drug Metab Pharmacokinet; 1996; 21(2):153-8. PubMed ID: 8839689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioequivalence. An updated reappraisal addressed to applications of interchangeable multi-source pharmaceutical products.
    Marzo A; Balant LP
    Arzneimittelforschung; 1995 Feb; 45(2):109-15. PubMed ID: 7710428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An approach for widening the bioequivalence acceptance limits in the case of highly variable drugs.
    Boddy AW; Snikeris FC; Kringle RO; Wei GC; Oppermann JA; Midha KK
    Pharm Res; 1995 Dec; 12(12):1865-8. PubMed ID: 8786957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Harmonization of testing drugs for bioequivalence: problems and possible solutions].
    Zherdev VP; Kolyvanov GB; Litvin AA; Sariev AK
    Eksp Klin Farmakol; 2003; 66(2):60-4. PubMed ID: 12962051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of average, population and individual bioequivalence in two- and four-period crossover studies.
    Wijnand HP
    Comput Methods Programs Biomed; 2003 Jan; 70(1):21-35. PubMed ID: 12468124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Veterinary drug bioequivalence determination.
    Toutain PL; Koritz GD
    J Vet Pharmacol Ther; 1997 Apr; 20(2):79-90. PubMed ID: 9131533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Types of bioequivalence and related statistical considerations.
    Hauck WW; Anderson S
    Int J Clin Pharmacol Ther Toxicol; 1992 May; 30(5):181-7. PubMed ID: 1592546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bio-International 92, conference on bioavailability, bioequivalence, and pharmacokinetic studies.
    Blume HH; Midha KK
    J Pharm Sci; 1993 Nov; 82(11):1186-9. PubMed ID: 7904641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Individual bioequivalence revisited.
    Chen ML; Lesko LJ
    Clin Pharmacokinet; 2001; 40(10):701-6. PubMed ID: 11707058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New guidelines for the assessment of bioavailability and bioequivalence].
    Blume H; Schug B; Tautz J; Erb K
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 May; 48(5):548-55. PubMed ID: 15887065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The subject-by-formulation interaction in multivariate bioequivalence.
    Cao L; Mathew T
    J Biopharm Stat; 2007; 17(3):367-79. PubMed ID: 17479387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating average bioequivalence using methods for high variability drugs: a case study.
    Sanchez MP; Gomez C; Carrasco JL; Ocana J; von Plessing C; Godoy CG; Reinbach R; Godoy R
    Int J Clin Pharmacol Ther; 2008 Oct; 46(10):527-37. PubMed ID: 18826867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bioequivalence studies of pharmaceutical preparations].
    Vetchý D; Frýbortová K; Rabisková M; Danecková H
    Cas Lek Cesk; 2007; 146(5):431-3. PubMed ID: 17554963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges associated with the evaluation of veterinary product bioequivalence: an AAVPT perspective.
    Martinez M; Langston C; Martin T; Conner D
    J Vet Pharmacol Ther; 2002 Jun; 25(3):201-20. PubMed ID: 12081616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of in vivo bioequivalence.
    Jackson AJ
    Pharm Res; 2002 Mar; 19(3):227-8. PubMed ID: 11934226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug bioequivalence. Recommendations from the Drug Bioequivalence Study Panel to the Office of Technology Assessment, Congress of the United States.
    J Pharmacokinet Biopharm; 1974 Oct; 2(5):433-66. PubMed ID: 4452945
    [No Abstract]   [Full Text] [Related]  

  • 17. Bioavailability and Bioequivalence Aspects of Oral Modified-Release Drug Products.
    Wang R; Conner DP; Li BV
    AAPS J; 2017 Mar; 19(2):360-366. PubMed ID: 28004346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing bioequivalence using genomic data.
    Chow SC; Shao J; Li L
    J Biopharm Stat; 2004 Nov; 14(4):869-80. PubMed ID: 15587969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioequivalence: the regulatory career of a pharmaceutical concept.
    Carpenter D; Tobbell DA
    Bull Hist Med; 2011; 85(1):93-131. PubMed ID: 21551918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioequivalence testing for locally acting gastrointestinal products: what role for gamma scintigraphy?
    Wilding I
    J Clin Pharmacol; 2002 Nov; 42(11):1200-10. PubMed ID: 12412818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.